Abstract |
Intratracheal instillation of Sephadex particles is a convenient model for assessing the impact of potential anti-inflammatory compounds on lung eosinophilia thought to be a key feature in asthma pathophysiology. However, the underlying cellular and molecular mechanisms involved are poorly understood. We have studied the time course of Sephadex-induced lung eosinophilia, changes in pulmonary T cell numbers, and gene and protein expression as well as the immunological and pharmacological modulation of these inflammatory indices in the Sprague Dawley rat. Sephadex increased T cell numbers (including CD4(+) T cells) and evoked a pulmonary eosinophilia that was associated with an increase in gene/ protein expression of the Th2-type cytokines IL-4, IL-5, and IL-13 and eotaxin in lung tissue. Sephadex instillation also induced airway hyperreactivity to acetylcholine and bradykinin. A neutralizing Ab (R73) against the alphabeta-TCR caused 54% depletion of total (CD2(+)) pulmonary T cells accompanied by a significant inhibition of IL-4, IL-13 and eotaxin gene expression together with suppression (65% inhibition) of eosinophils in lung tissue 24 h after Sephadex treatment. Sephadex-induced eosinophilia and Th2 cytokine gene and/or protein expression were sensitive to cyclosporin A and budesonide, compounds that inhibit T cell function, suggesting a pivotal role for T cells in orchestrating Sephadex-induced inflammation in this model.
|
Authors | El-Bdaoui Haddad, Stephen L Underwood, Dominika Dabrowski, Mark A Birrell, Kerryn McCluskie, Cliff H Battram, Michaela Pecoraro, Martyn L Foster, Maria G Belvisi |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 168
Issue 6
Pg. 3004-16
(Mar 15 2002)
ISSN: 0022-1767 [Print] United States |
PMID | 11884473
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Biomarkers
- Cytokines
- Dextrans
- Interleukin-2
- Budesonide
- Cyclosporine
- sephadex
- Acetylcholine
- Bradykinin
|
Topics |
- Acetylcholine
(administration & dosage)
- Animals
- Antibodies, Monoclonal
(administration & dosage)
- Biomarkers
(analysis)
- Bradykinin
(administration & dosage)
- Bronchial Hyperreactivity
(chemically induced)
- Budesonide
(therapeutic use)
- Cell Movement
(drug effects, immunology)
- Cells, Cultured
(drug effects, immunology, metabolism)
- Cyclosporine
(therapeutic use)
- Cytokines
(biosynthesis, genetics)
- Dextrans
(toxicity)
- Gene Expression Regulation
(drug effects, immunology)
- Inflammation
(chemically induced, drug therapy, immunology, metabolism)
- Interleukin-2
(biosynthesis)
- Intubation, Intratracheal
- Lung
(drug effects, immunology, metabolism, pathology)
- Lymphocyte Depletion
- Male
- Mast Cells
(drug effects, immunology)
- Pulmonary Eosinophilia
(chemically induced, immunology)
- Rats
- Rats, Sprague-Dawley
- T-Lymphocyte Subsets
(drug effects, immunology, metabolism)
- Time Factors
|